News
Desguaces y Chatarras Pedrós renews with the IRBLleida
To promote biomedical research in Lleida
A clinical trial led from Lleida uses oral iron molecules in large people with heart failure
The PREFER trial has been recognised as innovative for using oral iron molecules and targeting a particularly vulnerable population: large people with advanced heart disease, usually excluded from other trials
